(Total Views: 560)
Posted On: 05/05/2022 8:47:14 PM
Post# of 153617
I agree, we are not going to see .24 SP again.
We have a fairly straight forward plan on NASH and some real possibilities with some combination therapies that Dr. Kelly mention in a study. This study is intended to determine the potential synergistic therapeutic efficacy of leronlimab in combination therapies. Time to get HIV back on track and mTNBC as well and a partner for Long Covid.
My hope is some news so we get back to the $2.30 - 3.20 spot and then we can buy time. Would be real nice to have this hit with the rest of the market tanking, great time to invest in a bunch of different stocks.
We have a fairly straight forward plan on NASH and some real possibilities with some combination therapies that Dr. Kelly mention in a study. This study is intended to determine the potential synergistic therapeutic efficacy of leronlimab in combination therapies. Time to get HIV back on track and mTNBC as well and a partner for Long Covid.
My hope is some news so we get back to the $2.30 - 3.20 spot and then we can buy time. Would be real nice to have this hit with the rest of the market tanking, great time to invest in a bunch of different stocks.
(2)
(0)Scroll down for more posts ▼
